SynthesisThe oncologist2025

Dabrafenib and trametinib vs anti-PD(L)1 for the adjuvant treatment of locally advanced BRAF-mutant melanoma: a systematic review and meta-analysis.

Daniel V Araujo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.